Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Janssen Ortho LLC and Janssen Pharmaceuticals, Inc.
Current Parent CompanyJohnson & Johnson
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $5,900,000
Year: 2014
Date: March 6, 2014
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: Janssen agreed to pay $5.9 million in settlement of allegations it marketed its antipsychotic drug Risperdal for unapproved uses and hid dangers associated with the drug.
Level of Government: state
Action Type: agency action
Agency: Montana Attorney General
Civil or Criminal Case: civil
Facility State: Montana
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.